41
TaiGen Biotherapeutics
4157.TW·TWSETaipei TWFounded 2004100 employees
Micro CapbiotechPublicInfectious Disease
Platform: Taigexyn Antibio
Market Cap
$0.1B
All Drugs
2
Clinical Trials
5
Failed / Terminated
1
FDA Approved
1
Stock Price & Catalysts (4157.TW)
Loading 4157.TW stock data...
Drug Pipeline (2 programs)
| Drug Name | Code | Phase | Trials | Modality | Target | MOA | Indications |
|---|---|---|---|---|---|---|---|
| 415-7241 | 415-7241 | Phase 1 | 2 | HER2 | CFCRC | ||
| Rimabrutinib | 415-8615 | Approved | 3 | WRN | Parkinson'sLGS |
SEC Filings & Financial Documents
SEC filings are not available for TWSE-listed companies.
TaiGen Biotherapeutics trades on TWSE (TW). SEC EDGAR only covers US-listed issuers.
Insider Trading Activity
Insider trading data is not available for non-US exchanges.
Catalyst Events (5)